About ceoadmin

This author has not yet filled in any details.
So far ceoadmin has created 244 blog entries.

Drexel President John Fry To Receive William Penn Award

On May 19, the Chamber of Commerce for Greater Philadelphia will honor Drexel University President John Fry with its 2021 William Penn Award, the highest honor bestowed upon a business person in the Greater Philadelphia region. The award, which has been given annually since 1949, recognizes individuals for their outstanding contributions toward the betterment of the region, professional accomplishments, and commitment to charity as well as to the community.

Fry was appointed Drexel University’s 14th president in 2010. Under his leadership, Drexel has set a national example for the execution of public-private partnerships, and become a powerful force for economic development […]

Discovery Starts with CHOP’s Dr. Lindsey George

Talent looking to join Greater Philadelphia’s cell and gene therapy hub can hear firsthand from those living and working here about the types of opportunities the industry offers and the region’s quality of life. So far, seven talent ambassadors have shared their stories as part of the Chamber of Commerce for Greater Philadelphia’s “Discovery Starts with Me” series.

The most recent talent ambassador to talk about discovery in Greater Philadelphia is Dr. Lindsey George, an attending physician in the Division of Hematology and Director of Clinical In Vivo Gene Therapy at Children’s Hospital of Philadelphia (CHOP), as well as an Assistant […]

Big4Bio Publishes Philadelphia Life Sciences Report with 2022 Outlook

The CEO Council was pleased to again contribute to Big4Bio’s annual 2021 Philadelphia Year-in-Review report by providing a look forward to what we might expect in the region’s life sciences industry, including the cell and gene therapy sector, in 2022. The outlook is reprinted below and the link to the full report, as well as reports for the Boston, San Francisco Bay, and San Diego markets, can be found on Big4Bio’s website.

“These Year-in-Reviews reflect the constant growth of the life science industry in these Big4Bio regions and also help provide important information for 2022 […]

Gene Editing Researcher at ChristianaCare Contributes to Talent Series

ChristianaCare’s Gene Editing Institute is the latest organization to contribute to a video series building awareness of job opportunities in Greater Philadelphia’s cell and gene therapy and gene editing sectors. Created by the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth, in collaboration with its partners in the Cell & Gene Therapy and Connected Health Initiative, the “Discovery Starts with Me” video series shares what it is like to live and work in the region’s research hub. The series now features six “talent ambassadors” telling their stories.

For Natalia Rivera-Torres, Ph.D., the story is one […]

Region’s Cell & Gene Therapy Initiative Announces 2022 Plans

The Greater Philadelphia Cell & Gene Therapy and Connected Health Initiative, a multi-year project of the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth and 11 partner organizations that was launched in 2019, continues its efforts in 2022 to build awareness about the region’s leading cell and gene therapy hub.

“We anticipate another fantastically successful year in 2022 for Greater Philadelphia’s cell and gene therapy hub,” said Claire Marrazzo Greenwood, senior vice president of Economic Competitiveness for the Chamber and executive director of its CEO Council for Growth.

In 2022, the CEO Council for Growth and its […]

Region’s Quality of Life Is Focus of Talent Video Series

The terrific quality of life in Greater Philadelphia is a recurring theme of a new video series called “Discovery Starts With Me.” Created by the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth in collaboration with its partners in the Cell & Gene Therapy and Connected Health Initiative, and the hub’s cell and gene therapy R&D companies, each 90-second story gives a glimpse into what it’s like to live and work in the region.

The videos are shared on social media and as part of a paid campaign on LinkedIn. The intent is to build awareness of the opportunities […]

Year In Review: Region’s Cell & Gene Therapy Hub Saw Big Investment in 2021

Greater Philadelphia’s cell and gene therapy hub saw more than $3 billion invested in the sector in 2021, according to data from biopharma database company DealForma. The 17 firms in the region that are reflected in the tally include those performing research and commercial development, as well as a provider of products and services essential to the sector. The deal types range from seed-stage funding for Code Biotherapeutics Inc. to an IPO for Century Therapeutics and a SPAC (special purpose acquisition company) for Renovacor, Inc., in addition to several common stock offerings, several Series A and B rounds, and […]

Recent Articles Tell the Region’s Cell & Gene Therapy Story

Two recent articles are highlighting Greater Philadelphia’s prominence as a cell and gene therapy hub. “Both do a wonderful job of communicating the connectivity and collaboration in our region, said Claire Greenwood, executive director, CEO Council for Growth, and senior vice president, Economic Competitiveness at the Chamber of Commerce for Greater Philadelphia. “In combination, they reach a diverse audience and are a reflection of ongoing efforts by the Cell & Gene Therapy and Connected Health Initiative, in cooperation with our regional partners and stakeholders, to share the story of Greater Philadelphia’s leadership in cell and gene therapy.”

On November 23, The […]

Region’s Year-to-date Cell and Gene Therapy Sector Investment Exceeds $3 Billion

Investor enthusiasm for Greater Philadelphia’s cell and gene therapy sector continues with more than $3 billion invested in the region’s sector in 2021, according to data from biopharma database company DealForma (as of December 3). The 17 firms reflected in the tally include those performing research and commercial development as well as a provider of products and services essential to the sector.

The deal types range from seed-stage funding for Code Biotherapeutics Inc. to an IPO for Century Therapeutics and a SPAC (special purpose acquisition company) for Renovacor, Inc., in addition to some common stock offerings, several Series A and B […]

Go to Top